Aptose Biosciences Inc. logo
Aptose Announces Receipt of Deficiency Notice from Nasdaq
July 19, 2024 17:00 ET | Aptose Biosciences, Inc.
SAN DIEGO and TORONTO, July 19, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly...
Iovance.jpg
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
July 19, 2024 17:00 ET | Iovance Biotherapeutics, Inc.
SAN CARLOS, Calif., July 19, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) (“Iovance” or the “Company”), a biotechnology company focused on innovating, developing, and...
poet-logo@2018.png
POET Technologies Announces US$10 Million Registered Direct Offering
July 19, 2024 16:50 ET | POET Technologies Inc.
TORONTO, July 19, 2024 (GLOBE NEWSWIRE) -- POET Technologies Inc. ("POET" or the "Corporation") (TSXV: PTK; NASDAQ: POET), the designer and developer of the POET Optical Interposer™, Photonic...
CISO logo 2-color (11).png
CISO GLOBAL ANNOUNCES SOLUTION TO MITIGATE IMPACT OF CROWDSTRIKE SECURITY EVENT 
July 19, 2024 16:42 ET | CISO Global
Scottsdale, Ariz., July 19, 2024 (GLOBE NEWSWIRE) -- CISO Global (NASDAQ: CISO), CISO Global, an industry leader in proprietary software, managed cybersecurity, and compliance, announces that it has...
Monroe Capital Logo CMYK (1).jpg
Monroe Capital Corporation Schedules Second Quarter 2024 Earnings Release and Conference Call
July 19, 2024 16:23 ET | Monroe Capital Corporation
CHICAGO, July 19, 2024 (GLOBE NEWSWIRE) -- Monroe Capital Corporation (the “Company”) (NASDAQ: MRCC) announced today that it will report its second quarter 2024 financial results on Wednesday,...
EDAP-TMS_RGB-300dpi-20160111.png
EDAP Announces Interim Results from Phase 3 Study Evaluating Robotic HIFU for the Treatment of Deep Infiltrating Endometriosis
July 19, 2024 16:15 ET | EDAP TMS S.A.
        Robotic HIFU therapy continues to maintain an excellent safety profile, confirming positive safety data from prior Phase 1 and 2 studies in patients with deep infiltrating endometriosisAt...
Longeveron Logo.jpg
Longeveron Announces Closing of $9.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
July 19, 2024 16:05 ET | Longeveron
Longeveron announces closing of previously announced registered direct offering, raising $9 million in gross proceeds.
ultragenyx-CMYK.png
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
July 19, 2024 16:05 ET | Ultragenyx Pharmaceutical Inc.
NOVATO, Calif., July 19, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for...
remitly.jpg
Remitly to Report Second Quarter Financial Results on Wednesday, July 31, 2024
July 19, 2024 16:05 ET | Remitly Global, Inc.
SEATTLE, July 19, 2024 (GLOBE NEWSWIRE) -- Remitly Global, Inc. (NASDAQ: RELY) (“Remitly”), a trusted provider of digital financial services that transcend borders, today announced that it will...
Cumulus logo.png
Cumulus Media Announces Conference Call to Discuss Second Quarter 2024 Operating Results
July 19, 2024 16:01 ET | Cumulus Media Inc.
ATLANTA, July 19, 2024 (GLOBE NEWSWIRE) -- Cumulus Media Inc. (NASDAQ: CMLS) will host a conference call on Friday, August 2nd at 8:30 AM ET to discuss its second quarter 2024 operating results. A...